Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma have?
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma has 71 citations in the OpenAlex counts ScholarIQ stores.
When was Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma published?
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma has 2021 year in the ScholarIQ index.
What is the open-access status of Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma?
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma has gold oa status in the ScholarIQ index.
What is the DOI of Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma?
The DOI for Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma is on the source record.
What is the PMID of Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma?
The PMID for Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma is on the source record.
What is the OpenAlex record for Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma?
The OpenAlex for Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma is on the source record.